-
Mashup Score: 0Amy Schumer - I'm Sorry - 3 year(s) ago
This is “Amy Schumer – I’m Sorry” by E on Vimeo, the home for high quality videos and the people who love them.
Source: VimeoCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 12022 Cleveland Miles for Melanoma - 3 year(s) ago
The cure for melanoma begins with me…and the Miles for Melanoma community coming together to run, walk and raise funds for the Melanoma Research Foundation.
Source: join.melanoma.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
This Sunday 🌞 - it’s back! Cleveland @Miles4Melanoma 5K benefiting @CureMelanoma Donate to support your #CleClinicCancer Mean Girls Against Melanoma team! 🏃♂️🏃🏃♀️💪 https://t.co/eIGR5WuZAL
-
-
Mashup Score: 3Circulating Tumor DNA Testing Supports Rapid Therapeutic Decision-Making in Metastatic Melanoma: A Case Report - 3 year(s) ago
Treatment of metastatic melanoma includes the option of targeted therapy in patients with driver BRAF mutations. BRAF-MEK inhibitor drugs improve survival in the approximately 50% of patients with melanoma that harbor BRAF mutations. As BRAF mutation detection in tissue often takes days to weeks, it is not always possible or timely to obtain BRAF status in tissue using immunohistochemistry or…
Source: FrontiersCategories: Hem/Oncs, Latest HeadlinesTweet-
Newly published @FrontOncology ➡️ how to rapidly (same day) ctDNA profile for BRAF mutation, and utilize this newest #PrecisionOncology BRAF-targeted indication from @VivekSubbiah and team 👏 Work from @DocTapas @DNARNADan (and me!) thx to @BiocartisUS https://t.co/O9IMg0NV9W https://t.co/HegvzV6BtJ
-
-
Mashup Score: 9
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @JCO_ASCO: ⚠️ 🚀 ICYMI @ASCO #Guideline Rapid Recommendation Update: Systemic Therapy for #Melanoma https://t.co/LL5ZuX8G4x #melsm @Funch…
-
-
Mashup Score: 0Targeted next generation sequencing (NGS) to classify melanocytic neoplasms - PubMed - 3 year(s) ago
This study piloted a pan-solid-tumor next generation sequence (NGS)-based laboratory developed test as a diagnostic aid in melanocytic tumors. 31 cases (4 “epithelioid” nevi, 5 blue nevi variants, 7 Spitz tumors [3 benign and 4 malignant] and 15 melanomas) were evaluated. All tumors [median diameter …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
Only 7 years ago I was kindly advised by senior staff that genomics could not be used to diagnose cancer and to rely exclusively on histopath. At #CCDerm22 tricky pathologic diagnoses of melanocytic lesions elucidated with NGS sequencing 🧬@JenniferKo79 https://t.co/AKJiOEgGCE https://t.co/skFHjXjMW7
-
-
Mashup Score: 0Powered By - 3 year(s) ago
GiveSmart® is part of Community Brands, the leading provider of cloud-based software to associations, nonprofits, faith-based groups, and K-12 schools. Organizations adopt Community Brands solutions to manage memberships, career centers, learning, accounting, fundraising, donations, admissions, enrollment and events. © 2019 Community Brands HoldCo, LLC. All rights…
Source: e.givesmart.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Forget about the rankings (although yes that too), to be described as treating our patients like family, nothing better 💙 If you have the means to support @CleClinicKids they are an amazing team/family through good times and bad 🙏 https://t.co/i59GxhHx53 https://t.co/ytzJPkFqEq
-
-
Mashup Score: 1
Immune therapy and targeted therapies have led to durable responses and potential cures
Source: Consult QDCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @jamecancerdoc: The Changing Treatment Landscape for Patients with Metastatic Melanoma https://t.co/B7OemgPPko via @CleClinicMD @LucyBKe…
-
-
Mashup Score: 2The effects of immunotherapy and novel therapies on medical oncology work load in a Canadian province. - 3 year(s) ago
6532 Background: Both novel targeted therapies and immunotherapies have dramatically changed the landscape in a number of disease sites with previously limited treatment options. This has resulted in an impact on clinical workload for oncologists with subspecialty practices in the areas of non-small cell lung, (NSCLC), melanoma (M), and genitourinary (GU) cancer. Our aim was to investigate the…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
So proud of this #irAE22 session for APPs and RN care coordinators! Teletoxicity for cancers using IO and novel therapies has increased dramatically (https://t.co/Eicrc9P2v3) and our support staff need strategies to help improve communication with our patients through #irAEs https://t.co/rzhDeUyMZ6
-
-
Mashup Score: 1Management of Checkpoint Inhibitor-Related Toxicity - 3 year(s) ago
This program will bring together a multidisciplinary group of clinicians to share expertise and improve the care of patients receiving immune checkpoint inhibitor therapies.
Source: www.clevelandclinicmeded.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Link to register 👇 https://t.co/Xd1eXpdAie
-
-
Mashup Score: 7Management of Checkpoint Inhibitor-Related Toxicity - 3 year(s) ago
This program will bring together a multidisciplinary group of clinicians to share expertise and improve the care of patients receiving immune checkpoint inhibitor therapies.
Source: www.clevelandclinicmeded.comCategories: Latest Headlines, Oncologists1Tweet-
T-7 days for comprehensive virtual irAE updates, guidance! This year’s keynote speakers: ➡️GI irAE expert Yinghong Wang @MDAndersonNews ➡️nursing irAE expert @LKottschadeCNP @MayoClinic in a new nursing-specific session Register 👇 w 6mo recorded access https://t.co/Xd1eXpdAie https://t.co/9xjT9nzZ2s
-
Oh sorry forgot to link the video. And a couple more WIM @kmargolin @RSeedor @TranMDPhD @YanaNajjarMD @TaraGPhilly Sorry! 🥸😂😅 https://t.co/X9KlyUL14Y